首页 > 抗体蛋白 > 抗体
PerCP/Cyanine5.5 anti-mouse CD69 Antibody
产品名称:
PerCP/Cyanine5.5 anti-mouse CD69 Antibody
产品类别:
抗体
产品编号:
104521
产品应用:
104521
[价格]
规格 价格 库存
25µg ¥ 1416 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse dendritic epidermal T cell line Y245
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 ?g per 106 cells in 100 ?l. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Application Notes

The H1.2F3 antibody has been reported to augment T cell activation. Additional reported applications (for the relevant formats) include: in vitro T cell and NK cell activation1-3, immunohistochemistry4,5, and immunoprecipitation1.

This antibody has been characterized in the literature as containing a lambda (?) light chain.

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.

Application References

(PubMed link indicates BioLegend citation)
  1. Yokoyama WM, et al. 1988. J. Immunol. 141:369. (IP)
  2. Sobel ES, et al. 1993. J. Immunol. 150:673.
  3. Karlhofer FM, et al. 1991. J. Immunol. 146:3662.
  4. Zhou X, et al. 2005. J. Biol. Chem. 280:31240. (IHC)
  5. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC)
  6. Lawson BR, et al. 2007. J. Immunol. 178:5366.
  7. Lee JW, et al. 2006. Nature Immunol. 8:181.
  8. Epardaud M, et al. 2008. Cancer Res. 15:2972. PubMed
  9. Jordan JM, et al. 2008. 76:3717. PubMed
  10. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  11. Ishikawa C, et al. 2013. Biochim Biophys Acta. 167:99. PubMed
Product Citations
  1. Lucca L, et al. 2014. J Immunol. 193:3267. PubMed
  2. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  3. Ron–Harel N, et al. 2019. Cell Rep. 28:3011. PubMed
  4. Tan L, et al. 2019. Cell Rep. 27:3657. PubMed
  5. Lutes LK, et al. 2021. eLife. 10:00. PubMed
  6. Nijnik A, et al. 2009. J Immunol. 183:5788. PubMed
  7. Tritama E, et al. 2018. Hum Vaccin Immunother. 14:1524. PubMed
  8. Amor C, et al. 2020. Nature. 583:127. PubMed
  9. Soni C, et al. 2014. J Immunol. 193:4400. PubMed
  10. Schofield DJ, et al. 2021. MAbs. 13:1857100. PubMed
  11. Sinclair LV et al. 2019. Elife. 8 pii: e44210. PubMed
  12. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  13. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  14. Pham D, et al. 2019. Cell Rep. 29:1203. PubMed
  15. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  16. Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed
  17. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  18. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  19. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  20. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  21. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  22. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  23. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  24. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  25. Jeljeli M, et al. 2021. Front Immunol. 12:670776. PubMed
  26. Tomaru U et al. 2019. Cell reports. 26(3):639-651 . PubMed
  27. Zimmermann M, et al. 2019. Front Immunol. 10:829. PubMed
RRID
AB_940497 (BioLegend Cat. No. 104521) AB_2260065 (BioLegend Cat. No. 104522)

Antigen Details

Structure
C-type lectin, 27/33 kD
Distribution

Activated T cells and B cells, NK cells, granulocytes, thymocytes, platelets

Function
Lymphocyte activation
Cell Type
B cells, Granulocytes, NK cells, Platelets, T cells, Thymocytes, Tregs
Biology Area
Costimulatory Molecules, Immunology, Innate Immunity
Molecular Family
CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Testi R, et al. 1994. Immunol. Today 15:479.
3. Moretta A, et al. 1991. J. Exp. Med. 174:1393.
4. Yokoyama WM, et al. 1988. J. Immunol. 141:369.

Gene ID
12515 View all products for this Gene ID
UniProt
View information about CD69 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线